Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Acta Neurologica
|
August 1, 1994
Nicardipine versus propranolol in essential tumor
F J Jiménez-Jiménez, P J Garcia-Ruiz, F Cabrera-Valdivia
Revista De Neurologia
|
January 12, 2018
[Amimia in Parkinson's disease. Significance and correlation with the clinical features]
P J Garcia-Ruiz, C E Feliz-Feliz, T Maycas-Cepeda, et al.
Journal of the Neurological Sciences
|
September 27, 2008
Motor alterations are reduced in mice lacking the PARK2 gene in the presence of a human FTDP-17 mutant form of four-repeat tau
P Navarro, R Guerrero, E Gallego, et al.
Clinical Neuropharmacology
|
February 22, 2000
Bradykinesia in Huntington's disease
P J Garcia Ruiz, E Gomez Tortosa, V Sanchez Bernados, et al.
Archivos De Neurobiologia
|
September 1, 1990
[Clinical and epidemiologic characteristics of familial Parkinson disease]
B Morales, R Astarloa, R González Maldonado, et al.
Genetic Counseling (Geneva, Switzerland)
|
October 24, 2000
A MELAS phenotype and a paternal inherited inversion of chromosome 10 in a female patient
I Lorda-Sanchez, P J Garcia-Ruiz, M Rodriguez de Alba, et al.
Neurologia
|
August 4, 2018
Spanish expert consensus on the use of safinamide in Parkinson's disease
F Valldeoriola, F Grandas, J M Arbelo, et al.
Revista De Neurologia
|
May 13, 2017
[Myths and evidence on the use of botulinum toxin: spasticity in adults and in children with cerebral palsy]
J C Martinez-Castrillo, J L Pena-Segura, P Sanz-Cartagena, et al.
Neurologia
|
November 9, 2021
Spanish expert consensus on the use of safinamide in Parkinson's disease
F Valldeoriola, F Grandas, J M Arbelo, et al.
Revista De Neurologia
|
September 28, 2007
[Guide to the comprehensive treatment of spasticity]
F Vivancos-Matellano, S I Pascual-Pascual, J Nardi-Vilardaga, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Acta Neurologica
|
August 1, 1994
Nicardipine versus propranolol in essential tumor
F J Jiménez-Jiménez, P J Garcia-Ruiz, F Cabrera-Valdivia
Revista De Neurologia
|
January 12, 2018
[Amimia in Parkinson's disease. Significance and correlation with the clinical features]
P J Garcia-Ruiz, C E Feliz-Feliz, T Maycas-Cepeda, et al.
Journal of the Neurological Sciences
|
September 27, 2008
Motor alterations are reduced in mice lacking the PARK2 gene in the presence of a human FTDP-17 mutant form of four-repeat tau
P Navarro, R Guerrero, E Gallego, et al.
Clinical Neuropharmacology
|
February 22, 2000
Bradykinesia in Huntington's disease
P J Garcia Ruiz, E Gomez Tortosa, V Sanchez Bernados, et al.
Archivos De Neurobiologia
|
September 1, 1990
[Clinical and epidemiologic characteristics of familial Parkinson disease]
B Morales, R Astarloa, R González Maldonado, et al.
Genetic Counseling (Geneva, Switzerland)
|
October 24, 2000
A MELAS phenotype and a paternal inherited inversion of chromosome 10 in a female patient
I Lorda-Sanchez, P J Garcia-Ruiz, M Rodriguez de Alba, et al.
Neurologia
|
August 4, 2018
Spanish expert consensus on the use of safinamide in Parkinson's disease
F Valldeoriola, F Grandas, J M Arbelo, et al.
Revista De Neurologia
|
May 13, 2017
[Myths and evidence on the use of botulinum toxin: spasticity in adults and in children with cerebral palsy]
J C Martinez-Castrillo, J L Pena-Segura, P Sanz-Cartagena, et al.
Neurologia
|
November 9, 2021
Spanish expert consensus on the use of safinamide in Parkinson's disease
F Valldeoriola, F Grandas, J M Arbelo, et al.
Revista De Neurologia
|
September 28, 2007
[Guide to the comprehensive treatment of spasticity]
F Vivancos-Matellano, S I Pascual-Pascual, J Nardi-Vilardaga, et al.
Page
of 2